ClinicalTrials.gg
Active, not recruitingNCT06265116Updated Nov 10, 2026

One-Step Universal Adhesives: A 3-year Clinical Trial in Class II Composite Restorations

An interventional study of One-step universal adhesive in Dental Caries Class II and Marginal Integrity of Composite Restorations With Universal Adhesives, sponsored by Mansoura University. Active, not recruiting at 1 site in Egypt. Open to participants aged 20 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by Mansoura University · Not applicable, Interventional, and Treatment

How we know

Updated Nov 10, 20261 site added1 site removedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
20 Years to 40 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 19 studies in Dental Caries by Mansoura University — 5 open to participants now, 12 under way, none of them phase 3. Dental Caries · Mansoura University.

Planned enrollment
7th of 19
48 · median 40
Started
2024
with 4 others
No phase
19 of 19
5 open now
Primary completion
2027-01
later than 7 of 11 live
Registered
7th of 19
by date

Among the 19 studies in Dental Caries by Mansoura University, this one is the 7th largest by planned enrollment, is one of 5 that started in 2024, is one of 19 with no phase, reaches primary completion later than 7 of the 11 other live ones, and was the 7th registered.

Dental Caries

1,176 studies on the registry are indexed under Dental Caries; 209 are open to participants now.

Browse Dental Caries studies →

Open to participants now

5 of the 19 studies in Dental Caries by Mansoura University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 86 Dental Caries studies recruiting now, 18 (21%) set no upper age limit and 66 (77%) stop at 75 or younger; 60 take children under 18; 53 take healthy volunteers.

This study: 20 Years to 40 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 19 studies in Dental Caries by Mansoura University, or all of them as a file.
02

Study summary

to evaluate and compare the clinical performance and periodontal responses of four commercially available one-step universal adhesives with different formulations in Class II composite restorations over a three-year period.

Read the detailed description

The experimental design description adhered to the guidelines provided by the Consolidated Standards of Reporting Trials (CONSORT) statement. The present study is planned as a double-blinded randomized clinical trial, ensuring that both the patients and the examiner are unaware of the treatment allocation. The trial will follow a split-mouth design. A total of forty-eight adult patients, who are seeking dental treatment, will be enrolled in the study. The participants will be recruited from the Outpatient clinic at Faculty of Dentistry, Mansoura University.

No active advertisement will be used for participant recruitment, and instead, a convenience sample will be formed. Prior to participating in the study, each patient will be required to provide informed consent by signing a consent form. The protocol of the study was approved by Mansoura University's ethics committee before initiation

03

Conditions studied

  • Dental Caries Class II
  • Marginal Integrity of Composite Restorations With Universal Adhesives

Browse trials for

04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients must present with at least four posterior primary compound proximal caries involving two surfaces, specifically occluso-mesial or occluso-distal cavities, with a corresponding International Caries Detection and Assessment System (ICDAS) score of 4 or 5.
  • The buccolingual width of the lesion should be approximately less than two-thirds of the intercuspal distance.
  • Teeth to be restored must be in normal occlusion with the natural antagonist teeth.
  • Vital teeth with no signs of pulpal inflammation or pathological lesions.
  • Normal periodontal status and good oral hygiene.
  • Good likelihood of recall availability.

Exclusion criteria

Exclusion Criteria:

  • Patients with proximal cavities that extend beyond two surfaces or have a lesion buccolingual width greater than two-thirds of the intercuspal distance, or requiring cusp coverage.
  • Partly erupted or endodontic treated teeth.
  • Poor oral hygiene or severe periodontitis.
  • Absence of neighboring or antagonist teeth.
  • Patients with known allergy to any component of the study materials.
  • Patients with unstable medical conditions.
  • Patients with known unavailability to attend recall visits.
  • Pregnant or lactating females.
  • Patients with heavy para-functional habits, fractured, or visibly cracked teeth.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
48 participants (estimated)

Study arms

  • Active comparator
    Bis-GMA-containing, HEMA-containing, one-step universal adhesive.

    Each patient will randomly receive one class II restoration with one of the tested restorative systems

    Other: One-step universal adhesive

  • Active comparator
    Bis-GMA-free, HEMA-containing, one-step universal adhesive

    Each patient will randomly receive one class II restoration with one of the tested restorative systems

    Other: One-step universal adhesive

  • Active comparator
    Bis-GMA- free, HEMA-free, acrylic-based one-step universal adhesive

    Each patient will randomly receive one class II restoration with one of the tested restorative systems

    Other: One-step universal adhesive

  • Active comparator
    Bis-GMA- containing, HEMA-containing, amide-based one-step universal adhesive

    Each patient will randomly receive one class II restoration with one of the tested restorative systems

    Other: One-step universal adhesive

Interventions

  • OtherOne-step universal adhesive

    Each patient will receive a class II restoration using the corresponding group adhesive

06

What researchers measure

Primary outcomes

  1. Percentage of functional and biological properties for each group

    Percentage of functional and biological properties that will be clinically assessed using recently revised World Dental Federation parameters for each restorative system group

    Time frame: 3 years

07

Study locations

1 site
  • Omar Abd El-Fattah Abd El-Maksoud
    Al Mansurah, Dakahlia Governorate 35516, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2024 (actual). Primary completion is estimated for Jan 2027, 36 months after the start.

Of 470 non-industry interventional studies with no phase under Dental Caries, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's planned 36 months is above that.

Counting every sponsor, half of 503 studies reached it within 15 months; a quarter within 7 and three quarters within 29.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 6, 2024
First posted
Feb 20, 2024
StartActual
Jan 23, 2024
Primary completionEst.
Jan 23, 2027
CompletionEst.
Jan 30, 2027
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
1 site added, 1 site removed
Show site
  • Omar Abd El-Fattah Abd El-Maksoud · Al Mansurah, Egypt
Show 1 removed
  • Omar Abd El-Fattah Abd El-Maksoud · Mansoura, Egypt
Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    1 site added, 1 site removed
    Show site
    • Omar Abd El-Fattah Abd El-Maksoud · Al Mansurah, Egypt
    Show 1 removed
    • Omar Abd El-Fattah Abd El-Maksoud · Mansoura, Egypt
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06265116
Responsible party
Omar Abd El-fattah (Phd researcher, Mansoura University) — Principal investigator
First posted
Feb 20, 2024
Start date
Jan 23, 2024
Primary completion
Jan 23, 2027 (estimated)
Completion
Jan 30, 2027 (estimated)
Last update
Nov 10, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion